Cboe UK SEK

Arjo AB (publ) (ARJOBS.XC)

32.15
0.00
(0.00%)
At close: April 30 at 11:39:22 AM GMT+1
Loading Chart for ARJOBS.XC
  • Previous Close 32.15
  • Open 32.15
  • Bid 41.80 x --
  • Ask --
  • Day's Range 32.15 - 32.15
  • 52 Week Range 30.78 - 47.36
  • Volume 3,627
  • Avg. Volume 352
  • Market Cap (intraday) 8.351B
  • Beta (5Y Monthly) 0.57
  • PE Ratio (TTM) 19.02
  • EPS (TTM) 1.69
  • Earnings Date Jul 11, 2025
  • Forward Dividend & Yield 0.95 (2.95%)
  • Ex-Dividend Date Apr 30, 2025
  • 1y Target Est --

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobility, architects and planners, and rehabilitation services, as well as equipment repair and maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.

www.arjo.com

6,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ARJOBS.XC

View More

Performance Overview: ARJOBS.XC

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

ARJOBS.XC
6.10%
OMX Stockholm 30 Index (^OMX)
0.14%

1-Year Return

ARJOBS.XC
29.95%
OMX Stockholm 30 Index (^OMX)
6.13%

3-Year Return

ARJOBS.XC
53.13%
OMX Stockholm 30 Index (^OMX)
22.82%

5-Year Return

ARJOBS.XC
27.06%
OMX Stockholm 30 Index (^OMX)
59.41%

Compare To: ARJOBS.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ARJOBS.XC

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    7.84B

  • Enterprise Value

    8.43B

  • Trailing P/E

    19.02

  • Forward P/E

    15.38

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.77

  • Price/Book (mrq)

    1.12

  • Enterprise Value/Revenue

    0.74

  • Enterprise Value/EBITDA

    4.23

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.01%

  • Return on Assets (ttm)

    3.90%

  • Return on Equity (ttm)

    5.74%

  • Revenue (ttm)

    11.4B

  • Net Income Avi to Common (ttm)

    457M

  • Diluted EPS (ttm)

    1.69

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    609M

  • Total Debt/Equity (mrq)

    67.01%

  • Levered Free Cash Flow (ttm)

    683.5M

Research Analysis: ARJOBS.XC

View More

Company Insights: ARJOBS.XC

Research Reports: ARJOBS.XC

View More